Skip to content

DR. VAN GEMERT RUBEN

Active
Private limited companyfounded 2018active for 8 yearsHolvenstraat 192, 3900 Pelt, BelgiumKBO/BCE: BE 0702.805.283
Summary

DR. VAN GEMERT RUBEN has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €390,995 and a net result of €88,389. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 90% of 20,335 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€414,521total assets 2025
Equity
€390,995
Profit
€88,389
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 4 days early1 of 4 deeds read
Why 95lowers riskSector: Human health activities (NACE 86)Size: total assets €414,521Figures for financial year 2025 (filed 27-07-2026)Equity €390,995 (94.3% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 59% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 94.3% of total assets
Liquidity 58-42
short-term debt 5.6% · cash 6.6%
Profitability 95+3
return on assets 21.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,040 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity ample (current ratio 17.71, compared with 11.53 in 2024, above the usual 1.5; short-term debt: 5.6% and cash: 6.6% of total assets), and 5.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 35% on liquidity, 54% on profitability and 63% on growth.

The bankruptcy probability was computed on 13-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €414,521
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-07-2026)
NBB · annual accounts
lowers risk · Equity €390,995 (94.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
4 days early
2024
8 days late
2023
13 days early
2022
2 days early
2021
3 days late
2020
12 days late
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
14-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2018 to 2025net €88,389 ▲11.1%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 10% on solvencysector median 63.1% · 20,335 companies 94.3% View
  • Positive: 8 profitable years in a rowprofit 2025: €88,389 8 years View
  • Total assets 20256 financial years filed €414,521 View

By topic

Financials

Financial year
2025
Total assets
€414,521
Profit
€88,389
Solvency
94.3%
Total assets▼ 1.6%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2019
Next accounts
by 31-07-2027
  1. 05-08-2025Appointments: Ruben van Gemert (statutory director) and…
  2. 18-07-2024Annual accounts filed
  3. 31-12-2023Equity above €200,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
04-09-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.